CD274 and neoplasm: Recent studies have shown that the removal of ExoPD-L1 blocks tumor growth, even in mouse models which are resistant to anti-PD-L1 antibody (Chen G. et al., 2018; Yang et al., 2018; Kim et al., 2019; Poggio et al., 2019; Xie F. et al., 2019).